Cognitive therapy augmentation versus CT switch treatment: A Star*D report

International Journal of Cognitive Therapy

Volumn 2, Issue 1, 2009, Pages 66-87

  Friedman, Edward S ^d   Thase, Michael E ^d   Wisniewski, Stephen R ^b   Trivedi, Madhukar H ^a   Biggs, Melanie M ^a   Fava, Maurizio ^c   Warden, Diane ^a   Niederehe, George ^e   Luther, James F ^f   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887504791     PISSN: 19371209     EISSN: 19371217     Source Type: Journal    
DOI: 10.1521/ijct.2009.2.1.66     Document Type: Article

References (63)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Press.
2. American Psychiatric Association. (1993). Practice guidelines for major depressive disorder in adults. American Journal of Psychiatry, 150(suppl. 4), 1–26.
3. Blackburn, I.M., Eunson, K.M., & Bishop, S. (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders, 10, 67–75.
4. Bryant, M.J., Simons, A.D., & Thase, M.E. (1999). Therapist skill and patient variables in homework compliance; controlling an uncontrolled variable in cognitive therapy outcome research. Cognitive Therapy and Research, 23, 381–399.
5. Depression Guideline Panel. (1993). Clinical Practice Guideline, Number 5; Depression in Primary Care: Volume 2. Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research (AHCPR Publication No. 93-0551).
6. DeRubeis, R.J., Hollon, S.D., Amsterdam, J.D., Shelton, R.C., Young, P.R., Salomon, R.M., et al. (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62(4), 409-416.
7. Evans, M.D., Hollon, S.D., DeRubeis, R.J., Piasecki, J.M., Garvey, M.J., Grove, W.M., et al. (1992). Differential relapse following cognitive therapy and pharmacotherarpy of depression. Archives of General Psychiatry, 49, 802–808.
8. Fava, M., & Rush, A.J. (2006). Current status of augmentation and combination treatments for major depressive disorder: A literature review and a proposal for a novel approach to improve practice. Psychotherapy and Psychosomatics, 75(3), 139–153.
9. Fava, M., Alpert, J.E., Carmin, C.N., Wisniewski, S.R., Trevedi, M.H., Biggs, M.M., et al. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34, 1299–1308.
10. Fava, M., Rush, A.J., Alpert, J.E., Balasubramani, G.K., Wisniewski, S.R., Carmin, C.N., et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D Report. American Journal of Psychiatry, 165, 342–351.
11. Fava, M., Rush, A.J., Trivedi, M.H., Nierenberg, A., Thase, M., Sackeim, H., et al. (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America, 26(2), 457–94.
12. Fisher, L., Dixon, D., Herson, J., Frankowski, R., Hearron, M., & Peace, K. (1990). Intention-to-treat in clinical trials. In K.E. Peace (Ed.), Statistical Issues in Drug Research and Development. New York: Marcel Dekker.
13. Friedman, E.S. (1997). Combined therapy for depression. Journal of Practical Psychiatry and Behavioral Health, 3, 211–222.
14. Friedman, E.S., & Thase, M.E. (2006). Cognitive-behavioral therapy for depression and dysthymia. In D.J. Stein, D.J. Kupfer, and A.F. Schatzberg (Eds.), The Textbook of Mood Disorders (pp. 353–371). Washington, DC: American Psychiatric Publishing.
15. Friedman, E.S., Thase, M.E., Biggs, M.M., Carmin, C., Hollon, S.D., Kornblith, S.J., et al. (2004). The implementation of cognitive therapy in STAR*D. Cognitive Therapy and Research, 28, 819–833.
16. Friedman, E.S., Wright, J.H., & Thase, M.E. (2007). Combining cognitive therapy and medication for mood disorders. Psychiatric Annals, 36, 320–328.
17. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry, 23, 56–62.
18. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–96.
19. Hollon, S.D., DeRubeis, R.J., Shelton, R.C., Amsterdam, J.D., Salomon, R.M., O’Reardon, J.P., et al. (2005). Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Archives of General Psychiatry, 62, 417–422.
20. Hollon, S.D., Jarrett, R.B., Nierenberg, A.A., Thase, M.E., Trivedi, M., Rush, A.J., et al. (2005). Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment? Journal of Clinical Psychiatry, 66, 455–468.
21. Jacobson, N.S., & Hollon, S.D. (1996). Cognitive-behavior therapy versus pharmacotherapy: Now that the jury’s returned its verdict, it’s time to present the rest of the evidence. Journal of Consulting Clinical Psychology, 64, 74–80.
22. Jarrett, R.B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G., & Silver, P., et al. (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase: A randomized clinical trial. Archives of General Psychiatry, 58, 381–388.
23. Jindal, R.D., & Thase, M.E. (2003). Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders. Psychiatric Services, 54, 1484–1490.
24. Keller, M.B., McCullough, J.P., Klein, D.N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–1470.
25. Khan, A.Y., Carrithers, J., Preskorn, S.H., Wisniewski, S.R., Lear, R., Rush, A.J., et al. (2006). Clinical and demographic factors associated with DSM-IV melancholic de pression. Annals of Clinical Psychiatry, 18(2), 91–98.
26. Klerman, G.L., & Schechter, G.S. (1982). Drugs and psychotherapy. In E.S. Paykel (Ed.), Handbook of affective disorders (pp. 329–337). New York: Guilford Press.
27. Lavori, P.W., Rush, A.J., Wisniewski, S.R., Alpert, J., Fava, M., Kupfer, D.J., et al. (2001). Strengthening clinical effectiveness trials: Equipoise–Stratified Randomization. Biological Psychiatry, 50, 792–801.
28. Linn, B.S., Linn, M.W., & Gurel, L. (1968). Cumulative Illness Rating Scale. Journal of the American Geriatrics Society, 16, 622–26.
29. McCullough, J.P. (2000). Cognitive behavioral analysis system of psychotherapy: Treatment of chronic depression. New York: Guilford Press.
30. McPherson, S., Cairns, P., & Carlyle, J. (2005). The effectiveness of psychological treatments for treatment-resistant depression: A systematic review. Acta Psychiatrica Scandinavica, 111(5), 331–40.
31. Miller, M.D., Paradis, C.F., Houck, P.R., Mazumdar, S., Stack, J.A., Rifai, A.H., et al. (1992). Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Research, 41, 237–248.
32. Mundt, J.C. (1997). Interactive voice response systems in clinical research and treatment. Psychiatric Services, 48, 611–612.
33. Mundt, J.C., Marks, I.M., Shear, M.K., & Greist, J.M. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180, 461–464.
34. Nemeroff, C.B., Heim, C.M., Thase, M.E., Klein, D.K., Rush, A.J., Alan F. Schatzberg, A.F., et al. (2003). Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of The National Academy of Sciences of The United States of America, 100, 14293–14296.
35. Ninan, P.T., Rush, A.J., Crits-Cristoph, P., Kornstein, S.G., Manber, R., Thase, M.E., et al. (2002). Symptomatic and sydromal anxiety in chronic forms of major depression: Effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Journal of Clinical Psychiatry, 63, 434–441.
36. Novick, J.S., Stewart, J.W., Wisniewski, S.R., Cook, I.A., Manev, R., Nierenberg, A.A., et al. (2005). Clinical and demographic features of atypical depression in outpatients with major depression: Preliminary findings from STAR*D. Journal of Clinical Psychiatry, 66(8), 1002–1011.
37. Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004). Combined phar macotherapy and psychological treatment for depression: A systematic review. Archives of General Psychiatry, 61, 714–719.
38. Rush, A.J. (2007). STAR*D: What have we learned? American Journal of Psychiatry, 164(2), 201-204.
39. Rush, A.J., Fava, M., Wisniewski, S.R., Lavori, P.W., Trivedi, M.H., Sackeim, H.A., et al. (2004). Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25(1), 119–142.
40. Rush, A.J., & Thase, M.E. (1999). Psychotherapies for depressive disorders: A review. In M. Maj, and N. Sartorius (Eds.), WPA series evidence and experience in psychiatry: Depressive disorders (pp. 161-206). Chichester, UK: John Wiley & Sons, Ltd.
41. Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., et al. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54, 573–583.
42. Rush, A.J., Bernstein, I.H., Trivedi, M.H., Carmody, T.J., Wisniewski, S., Mundt, J.C., et al. (2006). An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression trial report. Biological Psychiatry, 59(6), 493–501.
43. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg, A.A., Thase, et al. (2006). For the STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Jounal of Medicine, 354(12), 1231–1242.
44. Rush, A.J., Zimmerman, J., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., et al. (2005). Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. Journal of Affective Disorders, 87, 43–55.
45. Schatzberg, A.F. (2003). Introduction: Treating depression and anxiety to remission. Journal of Clinical Psychiatry, 64 (Suppl 15), 3-4.
46. Schatzberg, A.F., Rush, A.J., Arnow, B.A., Banks, P.L., Blalock, J.A., Borian, F.E., et al. (2005). Chronic depression: Medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of General Psychiatry, 62(5), 513–520.
47. Scott, J. (1992). Chronic depression: Can cognitive therapy succeed when other treatments fail? Behavioural Psychotherapy, 20, 25–36.
48. Shaw, B.F. (1984). Specification of the training and evaluation of cognitive therapists for out-come studies. In J.B.W. Williams and R.L. Spitzer (Eds.), Psychotherapy research: Where we are and where should we go (pp. 173–189). New York: Guilford Press.
49. Shaw, B.F., Olmsted, M., Dobson, K.S., et al. (1999). Therapist Competence Ratings in Relation to Clinical Outcome in Cognitive Therapy of Depression. Journal of Consulting and Clinical Psychology, 67, 837–846.
50. Stimpson, N., Agrawal, N., & Lewis, G. (2002). Randomized controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review. British Journal of Psychiatry, 181, 284–294.
51. Thase, M.E. (2004). Comparing the efficacy of the newer antidepressants. In I. Gilaberte (Ed.), Neuvas Perspectivas en la Depresión (253-286). Madrid: Aula Médica Endiciones.
52. Thase, M.E. (2005). Bipolar depression: Issues in diagnosis and treatment. Harvard Review of Psychiatry, 13(5), 257-271.
53. Thase, M.E., Friedman, E.S., Biggs, M.M., et al. (2007). Cognitive therapy as a second-step treatment: A STAR*D Report. American Journal of Psychiatry, 164, 739–752.
54. Thase, M.E., Friedman, E.S., & Howland, R.H. (2001). Management of treatment-resistant depression: Psychotherapeutic perspectives. Journal of Clinical Psychiatry, 62(Suppl. 18), 18–24.
55. Thase, M.E., Rush, A.J., Manber, R., et al. (2002). Differential effects of nefazodone and cognitive-behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. Journal of Clinical Psychiatry, 63, 493–500.
56. Trivedi, M.H., Fava, M., Wisniewski, S.R., Thase, M.E., Quitkin, F., Warden, D., et al. (2006). For the STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine, 354(12), 1243–1252.
57. Trivedi, M.H., Rush, A.J., Ibrahim, H.M., et al. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychological Medicine, 34, 73–82.
58. Trivedi, M.H., Rush, A.J., Wisniewski, S.R., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 161, 28–40.
59. Williams, J.W., Rost, K., Dietrich, A.J., Ciotti, M.C., Zyzanski, S.J., & Cornell, J. (1999). Primary care physicians’ approach to depres sive disorders: Effects of physician specialty and practice. Archives of Family Medicine, 8, 58-67.
60. Wisniewski, S.R., Eng, H., Meloro, L., et al. (2004). Web-based communications and management of a multi-center clinical trial: The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. Clinical Trials, 1, 387–398.
61. Wisniewski, S.R., Fava, M., Trivedi, M.H., et al. (2007). Acceptability of second-step treatments to depressed outpatients: A STAR*D Report. American Journal of Psychiatry, 164, 1–8.
62. Wisniewski, S.R., Rush, A.J., Balasubramani, G.K., et al. (2006). for the STAR*D Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice, 12, 71–79.
63. Zimmerman, M., & Mattia, J.I. (1999). The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (The Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. Journal of Clinical Psychiatry, 60, 677–683.